This entity appears on both sides of lobbying disclosures. The firm tab shows registrant-reported income; the client tab shows client-reported lobbying spend. Contract awards are separate and are not included here.
Lobbying Spend
$14.9M
Filings
221
Firms Hired
4
Active Period
1999–2026
Client-reported lobbying expenses on LDA filings
Lobbying firms retained by this client; amounts are client-reported expenses when available
Government entities explicitly identified as targets in LDA filings
Most frequently reported lobbying issues
Bill numbers found in source-reported LDA specific issue text; broad topic matches are excluded
INSULIN Act of 2026
2026 · third_quarter · Firm: AMERICAN DIABETES ASSOCIATION
SAFE Drugs Act (H.R.6509/ S.3794); Diabetes Act (S. 4037) and competitive bidding program; INSULIN Act (H.R. 10227/ S. 4189); Diabetes foot health (H.R. 7905/H.R. 1616/S. 4070/ S. 1805); Childhood Diabetes Reduction Act (S. 5026); Special Diabetes Program Reauthorization (NIH and IHS); Appropriations for National Institutes of Health and Centers for Disease Control and Prevention; Issues related to insurance reform.
Client expense: $100,000 · Firm income: —
Matched citations: H.R. 10227
Promoting Access to Diabetic Shoes Act
2026 · third_quarter · Firm: AMERICAN DIABETES ASSOCIATION
SAFE Drugs Act (H.R.6509/ S.3794); Diabetes Act (S. 4037) and competitive bidding program; INSULIN Act (H.R. 10227/ S. 4189); Diabetes foot health (H.R. 7905/H.R. 1616/S. 4070/ S. 1805); Childhood Diabetes Reduction Act (S. 5026); Special Diabetes Program Reauthorization (NIH and IHS); Appropriations for National Institutes of Health and Centers for Disease Control and Prevention; Issues related to insurance reform.
Client expense: $100,000 · Firm income: —
Matched citations: H.R. 1616
SAFE Drugs Act of 2025
2026 · third_quarter · Firm: AMERICAN DIABETES ASSOCIATION
SAFE Drugs Act (H.R.6509/ S.3794); Diabetes Act (S. 4037) and competitive bidding program; INSULIN Act (H.R. 10227/ S. 4189); Diabetes foot health (H.R. 7905/H.R. 1616/S. 4070/ S. 1805); Childhood Diabetes Reduction Act (S. 5026); Special Diabetes Program Reauthorization (NIH and IHS); Appropriations for National Institutes of Health and Centers for Disease Control and Prevention; Issues related to insurance reform.
Client expense: $100,000 · Firm income: —
Matched citations: H.R.6509
Diabetes Foot Health Access and Modernization Act of 2026
2026 · third_quarter · Firm: AMERICAN DIABETES ASSOCIATION
SAFE Drugs Act (H.R.6509/ S.3794); Diabetes Act (S. 4037) and competitive bidding program; INSULIN Act (H.R. 10227/ S. 4189); Diabetes foot health (H.R. 7905/H.R. 1616/S. 4070/ S. 1805); Childhood Diabetes Reduction Act (S. 5026); Special Diabetes Program Reauthorization (NIH and IHS); Appropriations for National Institutes of Health and Centers for Disease Control and Prevention; Issues related to insurance reform.
Client expense: $100,000 · Firm income: —
Matched citations: H.R. 7905
Promoting Access to Diabetic Shoes Act
2026 · third_quarter · Firm: AMERICAN DIABETES ASSOCIATION
SAFE Drugs Act (H.R.6509/ S.3794); Diabetes Act (S. 4037) and competitive bidding program; INSULIN Act (H.R. 10227/ S. 4189); Diabetes foot health (H.R. 7905/H.R. 1616/S. 4070/ S. 1805); Childhood Diabetes Reduction Act (S. 5026); Special Diabetes Program Reauthorization (NIH and IHS); Appropriations for National Institutes of Health and Centers for Disease Control and Prevention; Issues related to insurance reform.
Client expense: $100,000 · Firm income: —
Matched citations: S. 1805
SAFE Drugs Act of 2026
2026 · third_quarter · Firm: AMERICAN DIABETES ASSOCIATION
SAFE Drugs Act (H.R.6509/ S.3794); Diabetes Act (S. 4037) and competitive bidding program; INSULIN Act (H.R. 10227/ S. 4189); Diabetes foot health (H.R. 7905/H.R. 1616/S. 4070/ S. 1805); Childhood Diabetes Reduction Act (S. 5026); Special Diabetes Program Reauthorization (NIH and IHS); Appropriations for National Institutes of Health and Centers for Disease Control and Prevention; Issues related to insurance reform.
Client expense: $100,000 · Firm income: —
Matched citations: S.3794
SAFE Drugs Act (H.R.6509/ S.3794); Diabetes Act (S. 4037) and competitive bidding program; INSULIN Act (H.R. 10227/ S. 4189); Diabetes foot health (H.R. 7905/H.R. 1616/S. 4070/ S. 1805); Childhood Diabetes Reduction Act (S. 5026); Special Diabetes Program Reauthorization (NIH and IHS); Appropriations for National Institutes of Health and Centers for Disease Control and Prevention; Issues related to insurance reform.
Client expense: $100,000 · Firm income: —
Matched citations: S. 4037
Diabetes Foot Health Access and Modernization Act of 2026
2026 · third_quarter · Firm: AMERICAN DIABETES ASSOCIATION
SAFE Drugs Act (H.R.6509/ S.3794); Diabetes Act (S. 4037) and competitive bidding program; INSULIN Act (H.R. 10227/ S. 4189); Diabetes foot health (H.R. 7905/H.R. 1616/S. 4070/ S. 1805); Childhood Diabetes Reduction Act (S. 5026); Special Diabetes Program Reauthorization (NIH and IHS); Appropriations for National Institutes of Health and Centers for Disease Control and Prevention; Issues related to insurance reform.
Client expense: $100,000 · Firm income: —
Matched citations: S. 4070
SAFE Drugs Act (H.R.6509/ S.3794); Diabetes Act (S. 4037) and competitive bidding program; INSULIN Act (H.R. 10227/ S. 4189); Diabetes foot health (H.R. 7905/H.R. 1616/S. 4070/ S. 1805); Childhood Diabetes Reduction Act (S. 5026); Special Diabetes Program Reauthorization (NIH and IHS); Appropriations for National Institutes of Health and Centers for Disease Control and Prevention; Issues related to insurance reform.
Client expense: $100,000 · Firm income: —
Matched citations: S. 4189
Childhood Diabetes Reduction Act of 2026
2026 · third_quarter · Firm: AMERICAN DIABETES ASSOCIATION
SAFE Drugs Act (H.R.6509/ S.3794); Diabetes Act (S. 4037) and competitive bidding program; INSULIN Act (H.R. 10227/ S. 4189); Diabetes foot health (H.R. 7905/H.R. 1616/S. 4070/ S. 1805); Childhood Diabetes Reduction Act (S. 5026); Special Diabetes Program Reauthorization (NIH and IHS); Appropriations for National Institutes of Health and Centers for Disease Control and Prevention; Issues related to insurance reform.
Client expense: $100,000 · Firm income: —
Matched citations: S. 5026
Minority Diabetes Initiative Act
2021 · first_quarter · Firm: AMERICAN DIABETES ASSOCIATION
H.R.1319, The American Rescue Plan Act. A COVID-19 relief bill that was signed into law, providing for nutrition benefits, financial assistance for health insurance coverage, and funding for COVID-19 testing and vaccine distribution in medically underserved communities. H.R. 7062, Affordable Insulin for the COVID-19 Emergency Act. A bill that eliminates copays for insulin in Medicare Part D during the COVID-19 national emergency period. H.R.4550, Minority Diabetes Initiative Act. Issues worked on not yet reflected in legislation: The Associations Health Equity Now initiative. The Association supports equitable access to a cure for diabetes through research, high-quality health care, diabetes drugs and management tools, healthy food and strong communities. The Associations Technology Access Project. The Association supports equitable access to critical diabetes management devices and supplies, such as continuous glucose monitors. The cost of prescription drugs. The Association supports a number of approaches to reducing the cost of prescription drugs such as insulin-particularly through pharmacy benefit manager (PBM) reform. Federal nutrition programs. The Association supports improvements to existing federal nutrition programs and access to nutrition education and healthy food, especially for individuals at higher risk of developing prediabetes or diabetes.
Client expense: $90,000 · Firm income: —
Matched citations: H.R.4550
Affordable Insulin for the COVID–19 Emergency Act
2021 · first_quarter · Firm: AMERICAN DIABETES ASSOCIATION
H.R.1319, The American Rescue Plan Act. A COVID-19 relief bill that was signed into law, providing for nutrition benefits, financial assistance for health insurance coverage, and funding for COVID-19 testing and vaccine distribution in medically underserved communities. H.R. 7062, Affordable Insulin for the COVID-19 Emergency Act. A bill that eliminates copays for insulin in Medicare Part D during the COVID-19 national emergency period. H.R.4550, Minority Diabetes Initiative Act. Issues worked on not yet reflected in legislation: The Associations Health Equity Now initiative. The Association supports equitable access to a cure for diabetes through research, high-quality health care, diabetes drugs and management tools, healthy food and strong communities. The Associations Technology Access Project. The Association supports equitable access to critical diabetes management devices and supplies, such as continuous glucose monitors. The cost of prescription drugs. The Association supports a number of approaches to reducing the cost of prescription drugs such as insulin-particularly through pharmacy benefit manager (PBM) reform. Federal nutrition programs. The Association supports improvements to existing federal nutrition programs and access to nutrition education and healthy food, especially for individuals at higher risk of developing prediabetes or diabetes.
Client expense: $90,000 · Firm income: —
Matched citations: H.R. 7062
American Rescue Plan Act of 2021
2021 · first_quarter · Firm: AMERICAN DIABETES ASSOCIATION
H.R.1319, The American Rescue Plan Act. A COVID-19 relief bill that was signed into law, providing for nutrition benefits, financial assistance for health insurance coverage, and funding for COVID-19 testing and vaccine distribution in medically underserved communities. H.R. 7062, Affordable Insulin for the COVID-19 Emergency Act. A bill that eliminates copays for insulin in Medicare Part D during the COVID-19 national emergency period. H.R.4550, Minority Diabetes Initiative Act. Issues worked on not yet reflected in legislation: The Associations Health Equity Now initiative. The Association supports equitable access to a cure for diabetes through research, high-quality health care, diabetes drugs and management tools, healthy food and strong communities. The Associations Technology Access Project. The Association supports equitable access to critical diabetes management devices and supplies, such as continuous glucose monitors. The cost of prescription drugs. The Association supports a number of approaches to reducing the cost of prescription drugs such as insulin-particularly through pharmacy benefit manager (PBM) reform. Federal nutrition programs. The Association supports improvements to existing federal nutrition programs and access to nutrition education and healthy food, especially for individuals at higher risk of developing prediabetes or diabetes.
Client expense: $90,000 · Firm income: —
Matched citations: H.R.1319
Expanding Access to DSMT Act of 2019
2020 · second_quarter · Firm: AMERICAN DIABETES ASSOCIATION
H.R. 1840/S. 814, the Expanding Access to Diabetes Self-Management Training (DSMT) Act. The Association supports this legislation to reduce barriers and increase the utilization of DSMT, which is a covered benefit under Medicare. (Lobbyists Used: Meghan Riley, Robert Goldsmith) S. 2199/H.R. 4906, The Insulin Price Reduction Act. The ADA supports this legislation which encourages lower insulin prices. (Lobbyists used: Meghan Riley, Rob Goldsmith) H.R. 2279, the Safe Step Act. The ADA supports this legislation which would require group health plans to provide an exceptions process for any medication step therapy protocol. (Lobbyists used: Meghan Riley, Rob Goldsmith) HR 4457, the Chronic Copay Elimination Act. The ADA supports this legislation which will require private health plans to cover preventive services, including screenings and certain medications, with no cost-sharing for people with chronic conditions such as diabetes. (Lobbyists used: Meghan Riley, Rob Goldsmith) HR 3, the Lower Drug Costs Now Act. This bill would require the HHS Secretary to negotiate prices for certain drugs including insulin. The ADA has not endorsed this legislation but does support specific provisions of this bill. (Lobbyists used: Rob Goldsmith, Meghan Riley) S. 2543, the Prescription Drug Pricing Reduction Act. This bill aims to lower the cost of prescription drugs in the Medicare and Medicaid programs and to improve drug pricing transparency. The ADA has not endorsed this legislation but does support specific provisions of this bill. (Lobbyists used: Rob Goldsmith, Meghan Riley) S. 3544, Coronavirus Relief for Seniors and People with Disabilities Act: The ADA supports this legislation which would address critical health and economic needs for older adults, people with disabilities, front-line workers and family caregivers. (Lobbyists used: Rob Goldsmith, Meghan Riley) Issues worked on not yet reflected in legislation: Protecting and strengthening the Affordable Care Act (ACA). The Association supports continued efforts to strengthen and improve the ACA which ensures access to affordable health coverage for people with diabetes. (Lobbyists used: Meghan Riley, Rob Goldsmith) Medicare Diabetes Prevention Program. The Association supports efforts to make CDC-recognized virtual diabetes prevention program (DPP) providers eligible for reimbursement in MDPP. (Lobbyists used: Rob Goldsmith, Meghan Riley) Child Nutrition Reauthorization. The Association supports protecting many programs (Summer Meals, School Breakfast Program, WIC) that are a part of the Healthy and Hunger-Free Kids Act, which was last reauthorized in 2010. (Lobbyists used: Deema Tarazi, Meghan Riley)
Client expense: $120,000 · Firm income: —
Matched citations: H.R. 1840
H.R. 1840/S. 814, the Expanding Access to Diabetes Self-Management Training (DSMT) Act. The Association supports this legislation to reduce barriers and increase the utilization of DSMT, which is a covered benefit under Medicare. (Lobbyists Used: Meghan Riley, Robert Goldsmith) S. 2199/H.R. 4906, The Insulin Price Reduction Act. The ADA supports this legislation which encourages lower insulin prices. (Lobbyists used: Meghan Riley, Rob Goldsmith) H.R. 2279, the Safe Step Act. The ADA supports this legislation which would require group health plans to provide an exceptions process for any medication step therapy protocol. (Lobbyists used: Meghan Riley, Rob Goldsmith) HR 4457, the Chronic Copay Elimination Act. The ADA supports this legislation which will require private health plans to cover preventive services, including screenings and certain medications, with no cost-sharing for people with chronic conditions such as diabetes. (Lobbyists used: Meghan Riley, Rob Goldsmith) HR 3, the Lower Drug Costs Now Act. This bill would require the HHS Secretary to negotiate prices for certain drugs including insulin. The ADA has not endorsed this legislation but does support specific provisions of this bill. (Lobbyists used: Rob Goldsmith, Meghan Riley) S. 2543, the Prescription Drug Pricing Reduction Act. This bill aims to lower the cost of prescription drugs in the Medicare and Medicaid programs and to improve drug pricing transparency. The ADA has not endorsed this legislation but does support specific provisions of this bill. (Lobbyists used: Rob Goldsmith, Meghan Riley) S. 3544, Coronavirus Relief for Seniors and People with Disabilities Act: The ADA supports this legislation which would address critical health and economic needs for older adults, people with disabilities, front-line workers and family caregivers. (Lobbyists used: Rob Goldsmith, Meghan Riley) Issues worked on not yet reflected in legislation: Protecting and strengthening the Affordable Care Act (ACA). The Association supports continued efforts to strengthen and improve the ACA which ensures access to affordable health coverage for people with diabetes. (Lobbyists used: Meghan Riley, Rob Goldsmith) Medicare Diabetes Prevention Program. The Association supports efforts to make CDC-recognized virtual diabetes prevention program (DPP) providers eligible for reimbursement in MDPP. (Lobbyists used: Rob Goldsmith, Meghan Riley) Child Nutrition Reauthorization. The Association supports protecting many programs (Summer Meals, School Breakfast Program, WIC) that are a part of the Healthy and Hunger-Free Kids Act, which was last reauthorized in 2010. (Lobbyists used: Deema Tarazi, Meghan Riley)
Client expense: $120,000 · Firm income: —
Matched citations: H.R. 2279
Elijah E. Cummings Lower Drug Costs Now Act
2020 · second_quarter · Firm: AMERICAN DIABETES ASSOCIATION
H.R. 1840/S. 814, the Expanding Access to Diabetes Self-Management Training (DSMT) Act. The Association supports this legislation to reduce barriers and increase the utilization of DSMT, which is a covered benefit under Medicare. (Lobbyists Used: Meghan Riley, Robert Goldsmith) S. 2199/H.R. 4906, The Insulin Price Reduction Act. The ADA supports this legislation which encourages lower insulin prices. (Lobbyists used: Meghan Riley, Rob Goldsmith) H.R. 2279, the Safe Step Act. The ADA supports this legislation which would require group health plans to provide an exceptions process for any medication step therapy protocol. (Lobbyists used: Meghan Riley, Rob Goldsmith) HR 4457, the Chronic Copay Elimination Act. The ADA supports this legislation which will require private health plans to cover preventive services, including screenings and certain medications, with no cost-sharing for people with chronic conditions such as diabetes. (Lobbyists used: Meghan Riley, Rob Goldsmith) HR 3, the Lower Drug Costs Now Act. This bill would require the HHS Secretary to negotiate prices for certain drugs including insulin. The ADA has not endorsed this legislation but does support specific provisions of this bill. (Lobbyists used: Rob Goldsmith, Meghan Riley) S. 2543, the Prescription Drug Pricing Reduction Act. This bill aims to lower the cost of prescription drugs in the Medicare and Medicaid programs and to improve drug pricing transparency. The ADA has not endorsed this legislation but does support specific provisions of this bill. (Lobbyists used: Rob Goldsmith, Meghan Riley) S. 3544, Coronavirus Relief for Seniors and People with Disabilities Act: The ADA supports this legislation which would address critical health and economic needs for older adults, people with disabilities, front-line workers and family caregivers. (Lobbyists used: Rob Goldsmith, Meghan Riley) Issues worked on not yet reflected in legislation: Protecting and strengthening the Affordable Care Act (ACA). The Association supports continued efforts to strengthen and improve the ACA which ensures access to affordable health coverage for people with diabetes. (Lobbyists used: Meghan Riley, Rob Goldsmith) Medicare Diabetes Prevention Program. The Association supports efforts to make CDC-recognized virtual diabetes prevention program (DPP) providers eligible for reimbursement in MDPP. (Lobbyists used: Rob Goldsmith, Meghan Riley) Child Nutrition Reauthorization. The Association supports protecting many programs (Summer Meals, School Breakfast Program, WIC) that are a part of the Healthy and Hunger-Free Kids Act, which was last reauthorized in 2010. (Lobbyists used: Deema Tarazi, Meghan Riley)
Client expense: $120,000 · Firm income: —
Matched citations: HR 3
Chronic Condition Copay Elimination Act
2020 · second_quarter · Firm: AMERICAN DIABETES ASSOCIATION
H.R. 1840/S. 814, the Expanding Access to Diabetes Self-Management Training (DSMT) Act. The Association supports this legislation to reduce barriers and increase the utilization of DSMT, which is a covered benefit under Medicare. (Lobbyists Used: Meghan Riley, Robert Goldsmith) S. 2199/H.R. 4906, The Insulin Price Reduction Act. The ADA supports this legislation which encourages lower insulin prices. (Lobbyists used: Meghan Riley, Rob Goldsmith) H.R. 2279, the Safe Step Act. The ADA supports this legislation which would require group health plans to provide an exceptions process for any medication step therapy protocol. (Lobbyists used: Meghan Riley, Rob Goldsmith) HR 4457, the Chronic Copay Elimination Act. The ADA supports this legislation which will require private health plans to cover preventive services, including screenings and certain medications, with no cost-sharing for people with chronic conditions such as diabetes. (Lobbyists used: Meghan Riley, Rob Goldsmith) HR 3, the Lower Drug Costs Now Act. This bill would require the HHS Secretary to negotiate prices for certain drugs including insulin. The ADA has not endorsed this legislation but does support specific provisions of this bill. (Lobbyists used: Rob Goldsmith, Meghan Riley) S. 2543, the Prescription Drug Pricing Reduction Act. This bill aims to lower the cost of prescription drugs in the Medicare and Medicaid programs and to improve drug pricing transparency. The ADA has not endorsed this legislation but does support specific provisions of this bill. (Lobbyists used: Rob Goldsmith, Meghan Riley) S. 3544, Coronavirus Relief for Seniors and People with Disabilities Act: The ADA supports this legislation which would address critical health and economic needs for older adults, people with disabilities, front-line workers and family caregivers. (Lobbyists used: Rob Goldsmith, Meghan Riley) Issues worked on not yet reflected in legislation: Protecting and strengthening the Affordable Care Act (ACA). The Association supports continued efforts to strengthen and improve the ACA which ensures access to affordable health coverage for people with diabetes. (Lobbyists used: Meghan Riley, Rob Goldsmith) Medicare Diabetes Prevention Program. The Association supports efforts to make CDC-recognized virtual diabetes prevention program (DPP) providers eligible for reimbursement in MDPP. (Lobbyists used: Rob Goldsmith, Meghan Riley) Child Nutrition Reauthorization. The Association supports protecting many programs (Summer Meals, School Breakfast Program, WIC) that are a part of the Healthy and Hunger-Free Kids Act, which was last reauthorized in 2010. (Lobbyists used: Deema Tarazi, Meghan Riley)
Client expense: $120,000 · Firm income: —
Matched citations: HR 4457
Insulin Price Reduction Act
2020 · second_quarter · Firm: AMERICAN DIABETES ASSOCIATION
H.R. 1840/S. 814, the Expanding Access to Diabetes Self-Management Training (DSMT) Act. The Association supports this legislation to reduce barriers and increase the utilization of DSMT, which is a covered benefit under Medicare. (Lobbyists Used: Meghan Riley, Robert Goldsmith) S. 2199/H.R. 4906, The Insulin Price Reduction Act. The ADA supports this legislation which encourages lower insulin prices. (Lobbyists used: Meghan Riley, Rob Goldsmith) H.R. 2279, the Safe Step Act. The ADA supports this legislation which would require group health plans to provide an exceptions process for any medication step therapy protocol. (Lobbyists used: Meghan Riley, Rob Goldsmith) HR 4457, the Chronic Copay Elimination Act. The ADA supports this legislation which will require private health plans to cover preventive services, including screenings and certain medications, with no cost-sharing for people with chronic conditions such as diabetes. (Lobbyists used: Meghan Riley, Rob Goldsmith) HR 3, the Lower Drug Costs Now Act. This bill would require the HHS Secretary to negotiate prices for certain drugs including insulin. The ADA has not endorsed this legislation but does support specific provisions of this bill. (Lobbyists used: Rob Goldsmith, Meghan Riley) S. 2543, the Prescription Drug Pricing Reduction Act. This bill aims to lower the cost of prescription drugs in the Medicare and Medicaid programs and to improve drug pricing transparency. The ADA has not endorsed this legislation but does support specific provisions of this bill. (Lobbyists used: Rob Goldsmith, Meghan Riley) S. 3544, Coronavirus Relief for Seniors and People with Disabilities Act: The ADA supports this legislation which would address critical health and economic needs for older adults, people with disabilities, front-line workers and family caregivers. (Lobbyists used: Rob Goldsmith, Meghan Riley) Issues worked on not yet reflected in legislation: Protecting and strengthening the Affordable Care Act (ACA). The Association supports continued efforts to strengthen and improve the ACA which ensures access to affordable health coverage for people with diabetes. (Lobbyists used: Meghan Riley, Rob Goldsmith) Medicare Diabetes Prevention Program. The Association supports efforts to make CDC-recognized virtual diabetes prevention program (DPP) providers eligible for reimbursement in MDPP. (Lobbyists used: Rob Goldsmith, Meghan Riley) Child Nutrition Reauthorization. The Association supports protecting many programs (Summer Meals, School Breakfast Program, WIC) that are a part of the Healthy and Hunger-Free Kids Act, which was last reauthorized in 2010. (Lobbyists used: Deema Tarazi, Meghan Riley)
Client expense: $120,000 · Firm income: —
Matched citations: H.R. 4906
Families First Coronavirus Response Act
2020 · second_quarter · Firm: AMERICAN DIABETES ASSOCIATION
H.R. 6201, the Families First Coronavirus Response Act. This bill would make emergency supplemental appropriations for the fiscal year ending September 30, 2020, which includes: ensuring that testing for the coronavirus is free; providing paid sick leave and paid family and medical leave for Americans impacted by this virus; strengthening nutrition assistance, in particular for children, seniors, and low-income families; and enhancing unemployment insurance. (Lobbyists used: Rob Goldsmith, Deema Tarazi, Meghan Riley) H.R. 748, Coronavirus Aid, Relief, and Economic Security Act or the CARES Act. A bill that provides $2 trillion to individuals, businesses, and states among others in response to the coronavirus pandemic under the Senate passed version. (Lobbyists used: Rob Goldsmith, Deema Tarazi, Meghan Riley) Issues worked on not yet reflected in legislation: 2021 reauthorization of the Special Diabetes Program (SDP). The Association supports renewal of both components of SDP. (Lobbyists used: Deema Tarazi, Meghan Riley) FY 2021 Defense Appropriations. Support inclusion of diabetes as an eligible research category for the Congressionally Directed Medical Research Program (Lobbyist used: Deema Tarazi, Meghan Riley, Contract Lobbyists) FY 2021 House/Senate Departments of Labor, Health and Human Services, and Education and Related Agencies (LHHS) Appropriations. ADA supports funding for the Division of Diabetes Translation and the National Diabetes Prevention Program at the CDC as well as funding for the NIDDK at the NIH. Our efforts are focused on increased funding for both of these agencies. (Lobbyists used: Meghan Riley, Deema Tarazi)
Client expense: $120,000 · Firm income: —
Matched citations: H.R. 6201
H.R. 6201, the Families First Coronavirus Response Act. This bill would make emergency supplemental appropriations for the fiscal year ending September 30, 2020, which includes: ensuring that testing for the coronavirus is free; providing paid sick leave and paid family and medical leave for Americans impacted by this virus; strengthening nutrition assistance, in particular for children, seniors, and low-income families; and enhancing unemployment insurance. (Lobbyists used: Rob Goldsmith, Deema Tarazi, Meghan Riley) H.R. 748, Coronavirus Aid, Relief, and Economic Security Act or the CARES Act. A bill that provides $2 trillion to individuals, businesses, and states among others in response to the coronavirus pandemic under the Senate passed version. (Lobbyists used: Rob Goldsmith, Deema Tarazi, Meghan Riley) Issues worked on not yet reflected in legislation: 2021 reauthorization of the Special Diabetes Program (SDP). The Association supports renewal of both components of SDP. (Lobbyists used: Deema Tarazi, Meghan Riley) FY 2021 Defense Appropriations. Support inclusion of diabetes as an eligible research category for the Congressionally Directed Medical Research Program (Lobbyist used: Deema Tarazi, Meghan Riley, Contract Lobbyists) FY 2021 House/Senate Departments of Labor, Health and Human Services, and Education and Related Agencies (LHHS) Appropriations. ADA supports funding for the Division of Diabetes Translation and the National Diabetes Prevention Program at the CDC as well as funding for the NIDDK at the NIH. Our efforts are focused on increased funding for both of these agencies. (Lobbyists used: Meghan Riley, Deema Tarazi)
Client expense: $120,000 · Firm income: —
Matched citations: H.R. 748
Insulin Price Reduction Act
2020 · second_quarter · Firm: AMERICAN DIABETES ASSOCIATION
H.R. 1840/S. 814, the Expanding Access to Diabetes Self-Management Training (DSMT) Act. The Association supports this legislation to reduce barriers and increase the utilization of DSMT, which is a covered benefit under Medicare. (Lobbyists Used: Meghan Riley, Robert Goldsmith) S. 2199/H.R. 4906, The Insulin Price Reduction Act. The ADA supports this legislation which encourages lower insulin prices. (Lobbyists used: Meghan Riley, Rob Goldsmith) H.R. 2279, the Safe Step Act. The ADA supports this legislation which would require group health plans to provide an exceptions process for any medication step therapy protocol. (Lobbyists used: Meghan Riley, Rob Goldsmith) HR 4457, the Chronic Copay Elimination Act. The ADA supports this legislation which will require private health plans to cover preventive services, including screenings and certain medications, with no cost-sharing for people with chronic conditions such as diabetes. (Lobbyists used: Meghan Riley, Rob Goldsmith) HR 3, the Lower Drug Costs Now Act. This bill would require the HHS Secretary to negotiate prices for certain drugs including insulin. The ADA has not endorsed this legislation but does support specific provisions of this bill. (Lobbyists used: Rob Goldsmith, Meghan Riley) S. 2543, the Prescription Drug Pricing Reduction Act. This bill aims to lower the cost of prescription drugs in the Medicare and Medicaid programs and to improve drug pricing transparency. The ADA has not endorsed this legislation but does support specific provisions of this bill. (Lobbyists used: Rob Goldsmith, Meghan Riley) S. 3544, Coronavirus Relief for Seniors and People with Disabilities Act: The ADA supports this legislation which would address critical health and economic needs for older adults, people with disabilities, front-line workers and family caregivers. (Lobbyists used: Rob Goldsmith, Meghan Riley) Issues worked on not yet reflected in legislation: Protecting and strengthening the Affordable Care Act (ACA). The Association supports continued efforts to strengthen and improve the ACA which ensures access to affordable health coverage for people with diabetes. (Lobbyists used: Meghan Riley, Rob Goldsmith) Medicare Diabetes Prevention Program. The Association supports efforts to make CDC-recognized virtual diabetes prevention program (DPP) providers eligible for reimbursement in MDPP. (Lobbyists used: Rob Goldsmith, Meghan Riley) Child Nutrition Reauthorization. The Association supports protecting many programs (Summer Meals, School Breakfast Program, WIC) that are a part of the Healthy and Hunger-Free Kids Act, which was last reauthorized in 2010. (Lobbyists used: Deema Tarazi, Meghan Riley)
Client expense: $120,000 · Firm income: —
Matched citations: S. 2199
Prescription Drug Pricing Reduction Act of 2019
2020 · second_quarter · Firm: AMERICAN DIABETES ASSOCIATION
H.R. 1840/S. 814, the Expanding Access to Diabetes Self-Management Training (DSMT) Act. The Association supports this legislation to reduce barriers and increase the utilization of DSMT, which is a covered benefit under Medicare. (Lobbyists Used: Meghan Riley, Robert Goldsmith) S. 2199/H.R. 4906, The Insulin Price Reduction Act. The ADA supports this legislation which encourages lower insulin prices. (Lobbyists used: Meghan Riley, Rob Goldsmith) H.R. 2279, the Safe Step Act. The ADA supports this legislation which would require group health plans to provide an exceptions process for any medication step therapy protocol. (Lobbyists used: Meghan Riley, Rob Goldsmith) HR 4457, the Chronic Copay Elimination Act. The ADA supports this legislation which will require private health plans to cover preventive services, including screenings and certain medications, with no cost-sharing for people with chronic conditions such as diabetes. (Lobbyists used: Meghan Riley, Rob Goldsmith) HR 3, the Lower Drug Costs Now Act. This bill would require the HHS Secretary to negotiate prices for certain drugs including insulin. The ADA has not endorsed this legislation but does support specific provisions of this bill. (Lobbyists used: Rob Goldsmith, Meghan Riley) S. 2543, the Prescription Drug Pricing Reduction Act. This bill aims to lower the cost of prescription drugs in the Medicare and Medicaid programs and to improve drug pricing transparency. The ADA has not endorsed this legislation but does support specific provisions of this bill. (Lobbyists used: Rob Goldsmith, Meghan Riley) S. 3544, Coronavirus Relief for Seniors and People with Disabilities Act: The ADA supports this legislation which would address critical health and economic needs for older adults, people with disabilities, front-line workers and family caregivers. (Lobbyists used: Rob Goldsmith, Meghan Riley) Issues worked on not yet reflected in legislation: Protecting and strengthening the Affordable Care Act (ACA). The Association supports continued efforts to strengthen and improve the ACA which ensures access to affordable health coverage for people with diabetes. (Lobbyists used: Meghan Riley, Rob Goldsmith) Medicare Diabetes Prevention Program. The Association supports efforts to make CDC-recognized virtual diabetes prevention program (DPP) providers eligible for reimbursement in MDPP. (Lobbyists used: Rob Goldsmith, Meghan Riley) Child Nutrition Reauthorization. The Association supports protecting many programs (Summer Meals, School Breakfast Program, WIC) that are a part of the Healthy and Hunger-Free Kids Act, which was last reauthorized in 2010. (Lobbyists used: Deema Tarazi, Meghan Riley)
Client expense: $120,000 · Firm income: —
Matched citations: S. 2543
Coronavirus Relief for Seniors and People with Disabilities Act of 2020
2020 · second_quarter · Firm: AMERICAN DIABETES ASSOCIATION
H.R. 1840/S. 814, the Expanding Access to Diabetes Self-Management Training (DSMT) Act. The Association supports this legislation to reduce barriers and increase the utilization of DSMT, which is a covered benefit under Medicare. (Lobbyists Used: Meghan Riley, Robert Goldsmith) S. 2199/H.R. 4906, The Insulin Price Reduction Act. The ADA supports this legislation which encourages lower insulin prices. (Lobbyists used: Meghan Riley, Rob Goldsmith) H.R. 2279, the Safe Step Act. The ADA supports this legislation which would require group health plans to provide an exceptions process for any medication step therapy protocol. (Lobbyists used: Meghan Riley, Rob Goldsmith) HR 4457, the Chronic Copay Elimination Act. The ADA supports this legislation which will require private health plans to cover preventive services, including screenings and certain medications, with no cost-sharing for people with chronic conditions such as diabetes. (Lobbyists used: Meghan Riley, Rob Goldsmith) HR 3, the Lower Drug Costs Now Act. This bill would require the HHS Secretary to negotiate prices for certain drugs including insulin. The ADA has not endorsed this legislation but does support specific provisions of this bill. (Lobbyists used: Rob Goldsmith, Meghan Riley) S. 2543, the Prescription Drug Pricing Reduction Act. This bill aims to lower the cost of prescription drugs in the Medicare and Medicaid programs and to improve drug pricing transparency. The ADA has not endorsed this legislation but does support specific provisions of this bill. (Lobbyists used: Rob Goldsmith, Meghan Riley) S. 3544, Coronavirus Relief for Seniors and People with Disabilities Act: The ADA supports this legislation which would address critical health and economic needs for older adults, people with disabilities, front-line workers and family caregivers. (Lobbyists used: Rob Goldsmith, Meghan Riley) Issues worked on not yet reflected in legislation: Protecting and strengthening the Affordable Care Act (ACA). The Association supports continued efforts to strengthen and improve the ACA which ensures access to affordable health coverage for people with diabetes. (Lobbyists used: Meghan Riley, Rob Goldsmith) Medicare Diabetes Prevention Program. The Association supports efforts to make CDC-recognized virtual diabetes prevention program (DPP) providers eligible for reimbursement in MDPP. (Lobbyists used: Rob Goldsmith, Meghan Riley) Child Nutrition Reauthorization. The Association supports protecting many programs (Summer Meals, School Breakfast Program, WIC) that are a part of the Healthy and Hunger-Free Kids Act, which was last reauthorized in 2010. (Lobbyists used: Deema Tarazi, Meghan Riley)
Client expense: $120,000 · Firm income: —
Matched citations: S. 3544
Expanding Access to Diabetes Self-Management Training Act of 2019
2020 · second_quarter · Firm: AMERICAN DIABETES ASSOCIATION
H.R. 1840/S. 814, the Expanding Access to Diabetes Self-Management Training (DSMT) Act. The Association supports this legislation to reduce barriers and increase the utilization of DSMT, which is a covered benefit under Medicare. (Lobbyists Used: Meghan Riley, Robert Goldsmith) S. 2199/H.R. 4906, The Insulin Price Reduction Act. The ADA supports this legislation which encourages lower insulin prices. (Lobbyists used: Meghan Riley, Rob Goldsmith) H.R. 2279, the Safe Step Act. The ADA supports this legislation which would require group health plans to provide an exceptions process for any medication step therapy protocol. (Lobbyists used: Meghan Riley, Rob Goldsmith) HR 4457, the Chronic Copay Elimination Act. The ADA supports this legislation which will require private health plans to cover preventive services, including screenings and certain medications, with no cost-sharing for people with chronic conditions such as diabetes. (Lobbyists used: Meghan Riley, Rob Goldsmith) HR 3, the Lower Drug Costs Now Act. This bill would require the HHS Secretary to negotiate prices for certain drugs including insulin. The ADA has not endorsed this legislation but does support specific provisions of this bill. (Lobbyists used: Rob Goldsmith, Meghan Riley) S. 2543, the Prescription Drug Pricing Reduction Act. This bill aims to lower the cost of prescription drugs in the Medicare and Medicaid programs and to improve drug pricing transparency. The ADA has not endorsed this legislation but does support specific provisions of this bill. (Lobbyists used: Rob Goldsmith, Meghan Riley) S. 3544, Coronavirus Relief for Seniors and People with Disabilities Act: The ADA supports this legislation which would address critical health and economic needs for older adults, people with disabilities, front-line workers and family caregivers. (Lobbyists used: Rob Goldsmith, Meghan Riley) Issues worked on not yet reflected in legislation: Protecting and strengthening the Affordable Care Act (ACA). The Association supports continued efforts to strengthen and improve the ACA which ensures access to affordable health coverage for people with diabetes. (Lobbyists used: Meghan Riley, Rob Goldsmith) Medicare Diabetes Prevention Program. The Association supports efforts to make CDC-recognized virtual diabetes prevention program (DPP) providers eligible for reimbursement in MDPP. (Lobbyists used: Rob Goldsmith, Meghan Riley) Child Nutrition Reauthorization. The Association supports protecting many programs (Summer Meals, School Breakfast Program, WIC) that are a part of the Healthy and Hunger-Free Kids Act, which was last reauthorized in 2010. (Lobbyists used: Deema Tarazi, Meghan Riley)
Client expense: $120,000 · Firm income: —
Matched citations: S. 814
Expanding Access to DSMT Act of 2019
2020 · second_quarter · Firm: AMERICAN DIABETES ASSOCIATION
H.R. 1840/S. 814, the Expanding Access to Diabetes Self-Management Training (DSMT) Act. The Association supports this legislation to reduce barriers and increase the utilization of DSMT, which is a covered benefit under Medicare. (Lobbyists Used: Meghan Riley, Robert Goldsmith) S. 2199/H.R. 4906, The Insulin Price Reduction Act. The ADA supports this legislation which encourages lower insulin prices. (Lobbyists used: Meghan Riley, Rob Goldsmith) H.R. 2279, the Safe Step Act. The ADA supports this legislation which would require group health plans to provide an exceptions process for any medication step therapy protocol. (Lobbyists used: Meghan Riley, Rob Goldsmith) HR 4457, the Chronic Copay Elimination Act. The ADA supports this legislation which will require private health plans to cover preventive services, including screenings and certain medications, with no cost-sharing for people with chronic conditions such as diabetes. (Lobbyists used: Meghan Riley, Rob Goldsmith) HR 3, the Lower Drug Costs Now Act. This bill would require the HHS Secretary to negotiate prices for certain drugs including insulin. The ADA has not endorsed this legislation but does support specific provisions of this bill. (Lobbyists used: Rob Goldsmith, Meghan Riley) S. 2543, the Prescription Drug Pricing Reduction Act. This bill aims to lower the cost of prescription drugs in the Medicare and Medicaid programs and to improve drug pricing transparency. The ADA has not endorsed this legislation but does support specific provisions of this bill. (Lobbyists used: Rob Goldsmith, Meghan Riley) S. 3544, Coronavirus Relief for Seniors and People with Disabilities Act: The ADA supports this legislation which would address critical health and economic needs for older adults, people with disabilities, front-line workers and family caregivers. (Lobbyists used: Rob Goldsmith, Meghan Riley) Issues worked on not yet reflected in legislation: Protecting and strengthening the Affordable Care Act (ACA). The Association supports continued efforts to strengthen and improve the ACA which ensures access to affordable health coverage for people with diabetes. (Lobbyists used: Meghan Riley, Rob Goldsmith) Medicare Diabetes Prevention Program. The Association supports efforts to make CDC-recognized virtual diabetes prevention program (DPP) providers eligible for reimbursement in MDPP. (Lobbyists used: Rob Goldsmith, Meghan Riley) Child Nutrition Reauthorization. The Association supports protecting many programs (Summer Meals, School Breakfast Program, WIC) that are a part of the Healthy and Hunger-Free Kids Act, which was last reauthorized in 2010. (Lobbyists used: Deema Tarazi, Meghan Riley)
Client expense: $120,000 · Firm income: —
Matched citations: H.R. 1840
Source: Senate LDA